Considerations in Weaning or Withdrawing Dupilumab Therapy-Nothing Is Forever

JAMA Dermatol. 2020 Feb 1;156(2):119-120. doi: 10.1001/jamadermatol.2019.3331.

Author

Peter A Lio^{1

2}

Affiliations

¹ Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Chicago Integrative Eczema Center, Chicago, Illinois.

PMID: 31876915
DOI: 10.1001/jamadermatol.2019.3331

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Dermatitis, Atopic*
Eczema*
Humans
Weaning

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
dupilumab